drugset / Trial / NCT04203342
A Therapeutic Equivalence Study of Ketoconazole Cream 2%
Phase 3
Completed
682 enrolled
Douglas Pharmaceuticals America Ltd
ACM Global Laboratories · collabNovum Pharmaceutical Research Services · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Clinical Study to Evaluate the Therapeutic Equivalence of Ketoconazole Cream 2% in the Treatment of Tinea Pedis.
Timeline
- Start
- 2019-12-11
- Primary completion
- 2020-05-28
- Completion
- 2020-07-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketoconazole | Small molecule | 2 % | Topical |